Jin Medical International Ltd. cash flow statement ZJYL
In fiscal 2025, which ended Sep 30, 2025, Jin Medical International Ltd. generated $2.9 million of cash from operations, up 340.5% from the year before. It spent $6.6 million on capital expenditures. Free cash flow was negative, at -$3.7 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2025
Sep 30, 2025
|
FY 2024
Sep 30, 2024
|
FY 2023
Sep 30, 2023
|
|---|---|---|---|
| Operating | |||
| Depreciation and amortization |
0
+2.3%
|
0
+5.3%
|
0
|
| Operating cash flow |
3
+340.5%
|
-1
-138.9%
|
3
|
| Investing | |||
| Capital expenditures |
7
+4473.9%
|
0
+27.2%
|
0
|
| Investing cash flow |
-11
-13.4%
|
-10
-23.1%
|
-8
|
| Financing | |||
| Short-term debt issued |
19
+53.1%
|
12
+119.1%
|
6
|
| Short-term debt repaid |
11
+105.6%
|
6
+292.1%
|
1
|
| Financing cash flow |
7
-36.9%
|
12
+68.6%
|
7
|
| Change in cash | |||
| Effect of exchange rate |
-0
-151.0%
|
0
|
—
|
| Net change in cash |
-1
-155.9%
|
1
-43.5%
|
2
|
| Free cash flow |
-4
-175.6%
|
-1
-145.2%
|
3
|
| Per share | |||
| Free cash flow per share |
-0.02
-175.4%
|
-0.01
-141.9%
|
0.02
|
| Ratios | |||
| Free cash flow margin |
-18.01%
|
-5.75%
|
15.10%
|
| Capital expenditures to revenue |
32.05%
|
0.62%
|
0.57%
|
| Cash conversion |
2.44x
|
-0.33x
|
1.08x
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- ZJYL (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Jiangsu Province, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1837821
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.